The cholinergics oral bethanechol (such as Urecholine
) [C] and injectable neostigmine (Prostigmin) [C] are used for urinary retention, and bethanechol is used for postpartum nonobstructive urinary retention.
has won FDA approval for its abbreviated new drug applications (ANDAs) for generic versions of Urecholine tablets (bethanechol chloride tablets USP), 5 mg, 10 rag, 25 mg and 50 mg.
markets Urecholine for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.
Prescription drugs like Urecholine
(bethanechol) and Reglan (metoclopramide) strengthen the esophageal sphincter and make the stomach empty faster.
A few other medications, such as Carafate, Urecholine
and Prilosec are also available.
He also may prescribe bethanechol (Urecholine
) or diazepam.
Much controversy surrounds the use of Urecholine
. This cholinergic medication is thought to increase bladder resting tone, which in turn should improve bladder emptying.
The evolution of the new entity came about through the purchase of the trademark and active ingredient for Urecholine
(bethanechol chloride tablets, USP) from the innovator company.
is the initial product launch of Odyssey, which has additional brand name product introductions in the planning stages.